E-LIB Suche - Ergebnisse für: Lee, Dong-Wan

1

Frequency based Classification of Activities using Accelero..:

Sharma, Annapurna ; Purwar, Amit ; Chung, Young-Dong Lee Young-Sook Lee Wan-Young
http://arxiv.org/abs/1107.4414. , 2011

Link: http://arxiv.org/abs/110..

2

Antimicrobial Cyclic Peptides for Plant Disease Control:

Lee, Dong Wan ; Kim, Beom Seok
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2015

Link: http://www.ncbi.nlm.nih...

3

Lazertinib Versus Gefitinib as First-Line Treatment in Pati..:

Cho, Byoung Chul ; Ahn, Myung-Ju ; Kang, Jin Hyoung...
Journal of Clinical Oncology, Vol.41 No.26, pp.4208-+. , 2023

Link: https://hdl.handle.net/1..

4

BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibito..:

Lim, Sun Min ; Fujino, Toshio ; Kim, Chulwon...
Clinical Cancer Research, Vol.29 No.16, pp.3004-3016. , 2023

Link: https://hdl.handle.net/1..

5

Asian Thoracic Oncology Research Group (ATORG) Expert Conse..:

Ahn, Myung-Ju ; Mendoza, Marvin Jonne L ; Pavlakis, Nick...
Clinical Lung Cancer, Vol.23 No.8, pp.670-685. , 2023

Link: https://hdl.handle.net/1..

6

Subchronic pulmonary toxicity of ambient particles containi..:

Park, Eun-Jung ; Yang, Mi-Jin ; Kang, Min-Sung...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372185/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mu..:

Cho, Byoung Chul ; Kim, Dong-Wan ; Spira, Alexander I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579096/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Stu..:

Zhou, Qing ; Soo, Ross A ; Chang, Gee-Chen...
JTO Clinical and Research Reports, Vol.4 No.5, p. 100499. , 2023

Link: https://hdl.handle.net/1..

9

The antitumor activity of a novel GCN2 inhibitor in head an..:

Lee, Jeongjae ; Keam, Bhumsuk ; Kim, Soyeon...
Translational Oncology, Vol.27, p. 101592. , 2023

Link: https://hdl.handle.net/1..

10

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Stu..:

Zhou, Qing ; Soo, Ross A ; Chang, Gee-Chen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200970/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Efficacy and Safety of Brigatinib Compared With Crizotinib ..:

Ahn, Myung J ; Kim, Hye R ; Yang, James C. H...
Clinical Lung Cancer, Vol.23 No.8, pp.720-730. , 2023

Link: https://hdl.handle.net/1..

12

A Phase II Study of Osimertinib in Patients with Advanced-S..:

Ang, Yvonne L. E ; Zhao, Xiaotian ; Reungwetwattana, Thanyanan...
Cancers, Vol.15 No.20, p. 4999. , 2023

Link: https://hdl.handle.net/1..

13

Is aryl hydrocarbon receptor antagonism after ischemia effe..:

Kwon, Jae-Im ; Heo, Hwon ; Chae, Yeon Ji...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189182/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Cerebral Glutamate Alterations Using Chemical Exchange Satu..:

Lee, Do-Wan ; Kwon, Jae-Im ; Heo, Hwon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224036/. , 2023

Link: http://www.ncbi.nlm.nih...

15

BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibito..:

Lim, Sun Min ; Fujino, Toshio ; Kim, Chulwon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425724/. , 2023

Link: http://www.ncbi.nlm.nih...